Pedro M. B.
- Country
- Portugal
- Department
- Dermatology Department
Research Overview
- Phase 3 Extension Study of Long-Term Safety and Efficacy of Remibrutinib in Adults With Moderate to Severe Hidradenitis Suppurativa
- Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of Upadacitinib in Adolescents and Adults with Moderate to Severe Atopic Dermatitis
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Upadacitinib in Moderate to Severe Hidradenitis Suppurativa Post Anti-TNF Therapy Failure
Data & Insights
Has run more than one trial at 220 of 438 partner sites.
Specializations
Autoimmune Skin Conditions
This investigator specializes in treating complex cutaneous lupus erythematosus, including both subacute and chronic forms. Their research encompasses therapeutic approaches for patients who have shown resistance or intolerance to conventional antimalarial treatments.
- Subacute Cutaneous Lupus Erythematosus (SCLE)
- Chronic Cutaneous Lupus Erythematosus (CCLE)
The investigator's work addresses both localized skin manifestations and cases with systemic involvement.
Inflammatory Skin Disorders
The investigator focuses on treating severe dermatological conditions, including plaque psoriasis and hidradenitis suppurativa. Their expertise extends to evaluating novel therapeutic approaches for these challenging skin conditions.
- Moderate to Severe Plaque Psoriasis
- Hidradenitis Suppurativa
Their research examines long-term treatment strategies and response patterns in chronic inflammatory skin conditions.
Pediatric Dermatology
The investigator has particular interest in atopic dermatitis affecting adolescent populations. Their work focuses on innovative therapeutic approaches for managing moderate-to-severe cases in younger patients.
- Adolescent Atopic Dermatitis
- Moderate to Severe Dermatitis Cases
The research encompasses safety and efficacy evaluations of new treatments for adolescent dermatological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.